9.40

1.26% -0.12

Nuvation Bio Inc (NUVB)

Overview News Price History Option Chain Discussions Forecast

Nuvation Bio Inc stock is traded at $9.40, with a volume of 3.60M. It is down -1.26% in the last 24 hours and up +17.35% over the past month. Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Previous Close:

$9.52

Open:

$9.54

24h Volume:

3.60M

Relative Volume:

0.42

Market Cap:

$3.22B

Revenue:

Net Income/Loss:

$-75.80M

P/E Ratio:

-26.86

EPS:

-0.35

Net Cash Flow:

$-68.07M

1W Performance:

-0.42%

1M Performance:

+17.35%

6M Performance:

+377.16%

1Y Performance:

+233.33%

1-Day Range:

$9.26

$9.56

1-Week Range:

$9.06

$9.75

52-Week Range:

$1.54

$9.75

Nuvation Bio Inc Stock (NUVB) Company Profile

Name

Nuvation Bio Inc

Sector

Healthcare (1131)

Industry

Biotechnology (633)

Phone

(415) 754-3517

Address

357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO

Employee

291

Twitter

Next Earnings Date

2025-03-05

Latest SEC Filings

NUVB's Discussions on Twitter

Compare NUVB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NUVB Nuvation Bio Inc	9.40	3.26B	0	-75.80M	-68.07M	-0.35
VRTX Vertex Pharmaceuticals Inc	462.90	117.47B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	784.97	82.37B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	400.59	52.94B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	844.92	52.33B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	177.88	37.84B	447.02M	-1.18B	-906.14M	-6.1812

Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-24-25	Initiated	Truist	Buy
Nov-19-25	Initiated	B. Riley Securities	Buy
Sep-30-25	Initiated	Jefferies	Buy
Apr-23-25	Initiated	Citizens JMP	Mkt Outperform
Mar-27-24	Upgrade	Jefferies	Hold → Buy
Mar-26-24	Upgrade	BTIG Research	Neutral → Buy
Jan-06-23	Downgrade	Jefferies	Buy → Hold
Aug-02-22	Downgrade	BMO Capital Markets	Outperform → Market Perform
Aug-02-22	Downgrade	BTIG Research	Buy → Neutral
May-04-22	Initiated	H.C. Wainwright	Buy
Oct-15-21	Resumed	BTIG Research	Buy
Apr-06-21	Initiated	RBC Capital Mkts	Outperform
Mar-08-21	Initiated	BMO Capital Markets	Outperform
Mar-08-21	Initiated	BTIG Research	Buy
Mar-08-21	Initiated	Cowen	Outperform
Mar-08-21	Initiated	Jefferies	Buy
Mar-08-21	Initiated	Wedbush	Outperform

View All

Nuvation Bio Inc Stock (NUVB) Latest News

Dec 23, 2025

Why Nuvation Bio Inc. Warrants stock gets analyst attentionJuly 2025 Retail & Free Verified High Yield Trade Plans - Улправда

Dec 20, 2025

How Nuvation Bio Inc. Warrants stock responds to bond marketInflation Watch & Weekly Watchlist for Hot Stocks - Улправда

Dec 20, 2025

Trading Recap: Will Nuvation Bio Inc. stock outperform growth indexes2025 Market WrapUp & AI Based Buy/Sell Signal Reports - Улправда

Dec 20, 2025

Dec 19, 2025

How Nuvation Bio Inc. stock reacts to oil pricesProfit Target & Safe Swing Trade Setup Alerts - Bölüm Sonu Canavarı

Dec 19, 2025

Wall Street Analysts Believe Nuvation Bio (NUVB) Could Rally 25.14%: Here's is How to Trade - Yahoo Finance

Dec 19, 2025

Is Nuvation Bio Inc. stock positioned for long term growthTrade Ideas & Expert Approved Momentum Ideas - DonanımHaber

Dec 19, 2025

Why Nuvation Bio Inc. stock is trending among retail tradersQuarterly Earnings Report & Short-Term High Return Ideas - DonanımHaber

Dec 19, 2025

How Nuvation Bio Inc. stock reacts to bond yieldsMarket Movement Recap & Fast Gaining Stock Reports - DonanımHaber

Dec 19, 2025

Why Nuvation Bio Inc. Class stock could be next leaderJuly 2025 Outlook & Reliable Entry Point Alerts - DonanımHaber

Dec 19, 2025

Dec 18, 2025

Nuvation Bio (NYSE:NUVB) Reaches New 52-Week HighStill a Buy? - MarketBeat

Dec 18, 2025

Nuvation Bio stock hits 52-week high at 8.96 USD By Investing.com - Investing.com Canada

Dec 18, 2025

Nuvation Bio stock hits 52-week high at 8.96 USD - Investing.com

Dec 18, 2025

Will Nuvation Bio Inc. stock outperform growth indexesMarket Sentiment Summary & Entry Point Confirmation Alerts - Улправда

Dec 18, 2025

How buyback programs support Nuvation Bio Inc. Class stockJuly 2025 Momentum & Fast Exit/Entry Strategy Plans - Улправда

Dec 18, 2025

Dec 17, 2025

Nuvation Bio Sees Unusually Large Options Volume (NYSE:NUVB) - MarketBeat

Dec 17, 2025

Has Nuvation Bio’s 234% Surge in 2025 Already Reflected Its Growth Potential? - Yahoo Finance

Dec 17, 2025

Dec 16, 2025

Nuvation Bio (NUVB): Reassessing Valuation After a 78% Monthly Surge in the Share Price - Yahoo Finance

Dec 16, 2025

Is Nuvation Bio’s 228.6% 2025 Surge Still Supported by Valuation? - Sahm

Dec 16, 2025

Dec 15, 2025

Nuvation Bio Stock Logs Its Best Session Ever: Wall Street Turns Bullish On Lung Cancer Drug’s Blockbuster Debut - MSN

Dec 15, 2025

Nuvation Bio (NUVB) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Dec 15, 2025

FY2025 EPS Estimates for Nuvation Bio Boosted by Analyst - MarketBeat

Dec 15, 2025

Dec 12, 2025

Gap Down: How Nuvation Bio Inc stock reacts to oil prices2025 EndofYear Setup & High Conviction Buy Zone Picks - moha.gov.vn

Dec 12, 2025